Outcomes for critically ill patients with HIV and severe sepsis in the era of highly active antiretroviral therapy

Journal of Critical Care

Volumn 27, Issue 1, 2012, Pages 51-57

  Greenberg, Jared A ^a   Lennox, Jeffrey L ^a   Martin, Greg S ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Highly active antiretroviral therapy; Intensive care unit; Severe sepsis

Indexed keywords

ANTIRETROVIRUS AGENT;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; APACHE; ARTICLE; CD4 LYMPHOCYTE COUNT; COHORT ANALYSIS; COMMUNICABLE DISEASE; CRITICALLY ILL PATIENT; DISEASE SEVERITY; FEMALE; HIGHLY ACTIVE ANTIRETROVIRAL THERAPY; HOSPITAL INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INTENSIVE CARE; MAJOR CLINICAL STUDY; MALE; MORTALITY; PROGNOSIS; SEPSIS; VIRUS LOAD;

ACUTE DISEASE; ADULT; ANTIRETROVIRAL THERAPY, HIGHLY ACTIVE; COMMUNITY-ACQUIRED INFECTIONS; CRITICAL ILLNESS; CROSS INFECTION; FEMALE; GEORGIA; HIV INFECTIONS; HOSPITAL MORTALITY; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEPSIS; TREATMENT OUTCOME;

EID: 84856443803     PISSN: 08839441     EISSN: 15578615     Source Type: Journal    
DOI: 10.1016/j.jcrc.2011.08.015     Document Type: Article

References (22)

1. Coquet I., Pavie J., Palmer P., Barbier F., Legriel S., Mayaux J., et al. Survival trends in critically ill HIV-infected patients in the highly active antiretroviral therapy era. Crit Care 2010, 14:R107.
2. Casalino E., Wolff M., Ravaud P., Choquet C., Bruneel F., Regnier B. Impact of HAART advent on admission patterns and survival in HIV-infected patients admitted to an intensive care unit. AIDS 2004, 18:1429-1433.
3. Morris A., Creasman J., Turner J., Luce J.M., Wachter R.M., Huang L. Intensive care of human immunodeficiency virus-infected patients during the era of highly active antiretroviral therapy. Am J Respir Crit Care Med 2002, 166:262-267.
4. Narasimhan M., Posner A.J., DePalo V.A., Mayo P.H., Rosen M.J. Intensive care in patients with HIV infection in the era of highly active antiretroviral therapy. Chest 2004, 1800-1804.
5. Khouli H., Afrasiabi A., Shibli M., Hajal R., Barrett C.R., Homel P. Outcome of critically ill human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy. J Intensive Care Med 2005, 20:327-333.
6. Dickson S.J., Batson S., Copas A.J., Edwards S.G., Singer M., Miller R.F. Survival of HIV-infected patients in the intensive care unit in the era of highly active antiretroviral therapy. Thorax 2007, 62:964-968.
7. Vincent B., Timsit J.F., Auburtin M., Schortgen F., Bouadma L., Wolff M., et al. Characteristics and outcomes of HIV-infected patients in the ICU: impact of the highly active antiretroviral treatment era. Intensive Care Med 2004, 30:859-866.
8. Palacios R., Hidalgo A., Reina C., de la Torre M., Márquez M., Santos J. Effect of antiretroviral therapy on admissions of HIV-infected patients to an intensive care unit. HIV Med 2006, 7:193-196.
9. Powell K., Davis J.L., Morris A.M., Chi A., Bensley M.R., Huang L. Survival for patients With HIV admitted to the ICU continues to improve in the current era of combination antiretroviral therapy. Chest 2009, 135:11-17.
10. Huang L., Quartin A., Jones D., Havlir D.V. Intensive care of patients with HIV infection. N Engl J Med 2006, 355:173-181.
11. Pacheco A.G., Tuboi S.H., May S.B., Moreira L.F.S., Ramadas L., Nunes E.P., et al. Temporal changes in causes of death among HIV-infected patients in the HAART era in Rio de Janeiro, Brazil. J Acquir Immune Defic Syndr 2009, 51:624-630.
12. Japiassu A.M., Amancio R.T., Mesquita E.C., Medeiros D.M., Bernal H.B., Nunes E.P., et al. Sepsis is a major determinant of outcome in critically ill HIV/AIDS patients. Crit Care 2010, 14:R152.
13. Croda J., Croda M.G., Neves A. De Sousa dos Santos S: Benefit of antiretroviral therapy on survival of human immunodeficiency virus-infected patients admitted to an intensive care unit. Crit Care Med 2009, 37:1605-1611.
14. Bone R.C., Balk R.A., Cerra F.B., Dellinger R.P., Fein A.M., Knaus W.A., et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992, 101:1644-1655.
15. Horan T.C., Andrus M., Dudeck M.A. CDC/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting. Am J Infect Control 2008, 36:309-332.
16. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005, 171:388-416.
17. Padoveze M.C., Trabasso P., Branchini M.L. Nosocomial infections among HIV-positive and HIV-negative patients in a Brazilian infectious diseases unit. Am J Infect Control 2002, 30:346-350.
18. Petrosillo N., Pagani L., Ippolito G. Gruppo HIV e Infezioni Ospedaliere: nosocomial infections in HIV-positive patients: an overview. Infection 2003, (Suppl 2):28-34.
19. CDC. HIV Surveillance Report, Vol. 21; 2011.
20. Kaiser Family Foundation Black Americans and HIV/AIDS 2011.
21. Vargas-Infante Y.A., Guerrero M.L., Ruiz-Palacios G.M., Soto-Ramírez L.E., Del Río C., Carranza J., et al. Improving outcome of human immunodeficiency virus-infected patients in a Mexican intensive care unit. Arch Med Res 2007, 38:827-833.
22. Pulvirenti J.J., Glowacki R., Muppiddi U., Surapaneni N., Gail C., Kohl B., et al. Hospitalized HIV-infected patients in the HAART era: a view from the inner city. AIDS Patient Care STDS 2003, 17:565-573.